Navigation Links
Echinacea: Cold-Season Cure or Risk?

When sneezing and a prickly throat signal an oncoming cold, many people reach for what they believe will be a safe preventative – a tea or capsule containing //echinacea. In the first study to examine the effects of a botanical supplement on bacteria in the gastrointestinal tract, research at the University of Arkansas suggests people may be risking some unwelcome side effects with this common herbal remedy.

Although various botanical extracts have been shown in the laboratory to have some antimicrobial effects, previous to this research there had been no published information about their effect in vivo – in the human gastrointestinal tract. Research conducted by Jerald C. Foote, assistant professor of food and human nutrition, and graduate student Laura Hill yielded some surprising results and pointed to the need for further research.

The researchers worked with 15 healthy adults who took daily doses for 10 days of a supplement that offered a consistent amount of Echinacea purpurea, one of the commonly used varieties of Echinacea. The participants recorded any adverse effects, which proved to be minor. Stool specimens were collected and tested prior to using echinacea and again 10 days and 17 or 18 days following the supplementation.

Although the researchers had expected to see no result from the echinacea, they found that gastrointestinal bacterial counts increased for three groups of organisms during supplementation. Concentrations were increased for the total group of aerobic bacteria, and for the anaerobic Bacteroides in general and Bacteroides fragilis in particular. Anaerobic bacteria – those that grow where there is no oxygen – comprise the majority of the bacteria in the human colon. While Bacteroides are an important feature in the normal life of the colon, under certain conditions they also can act as pathogens, especially strains of B. fragilis.

Foote and Hill pointed out that increased Bacteroides concentr ations have been reported in people at high risk for colon cancer. Studies have shown that a specific strain of B. fragilis may contribute to inflammatory bowel disease and diarrhea.

The UA researchers noted that their study showed a significant increase in bacteria after only 10 days. They pointed out that the German Commission E, a body that sets guidelines for use of herbal products in Germany, suggests that echinacea can be used for up to eight weeks. In light of their research, Foote and Hill caution that “prolonged consumption could prove deleterious” to bacteria in the gastrointestinal tract, particularly for those who are ill.

Their research, they conclude, shows that larger studies are needed to target the specific bacteria affected and to determine whether particular components or the combination of components in echinacea affect bacteria in the human gastrointestinal tract.


Related medicine news :

1. Do Computer Factories Enhance Cancer Risk?
2. Osteoporosis Meds and Jaw Pain: Whats the Risk?
3. Chinese Food- a Global Risk?
4. Botox at Your Own Risk?
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... Santa Rosa, CA (PRWEB) , ... November 27, 2015 , ... ... Northern California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine ... dinner meeting. They observed that both STEMI and Sepsis conditions present in similar ways ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
Breaking Medicine Technology: